News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...

Recent Postings



Incyte (INCY) PORTOLA (PTLA) Vertex (VRTX) OSI (OSIP) Prolor Biotech (PBTH) ISIS (ISIS) ZALTRAP™ Aimmune Therapeutics (AIMT) Illumina (ILMN) Sangamo (SGMO) Ridaforolimus Intercept (ICPT) Herceptin Intrexon (XON) Intermune (ITMN) MODERNA Idenix (IDIX) SUNESIS PHARMACEUTICALS (SNSS) Global Cell Therapeutics (GBT) ARCA (ABIO) Ziofpharm (ZIOP) AERIE PHARMACEUTICALS Bellicum (BLCM) Ionis (IONS) Onyx (ONXX) BIOMARIN (BMRN) CEMPRA (CEMP) RenenxBio (RGNX) ImmunoGen (IMGN) Anadys (ANDS) Exelixis (EXEL) NANTKWEST (NK) SYNTA (SNTA) Theravance (THRX) Galena (GALE) ARGOS (ARGS) Biocryst (BCRX) NEUROCRINE (NBIX) GUARDIAN HEALTH Roche (ROCHE) Tysabri Array Pharmaceuticals (ARRY) INNOVIVA (INVA) IDERA (IDRA) KITE (KITE) Sanofi-Aventis (SAN) Spike Therapeutics (ONCE) Human Genome Sciences (HGSI) Elan (ELN) Prosensa (RNA) Ocular Therapeutix (OCUL) Bristol-Myers Squibb (BMY) Telaprevir Dynavax (DVAX) CompuGen (CGEN) Jazz Pharmaceuticals (JAZZ) Mirati Therapeutics (MRTX) HALOZYME (HALO) galapagos (GLPG) Vitae Pharmaceuticals (VTAE) Endometrial Cancer C4 Therapeutics Valeant Pharmaceuticals International (VRX) Roche (RHHBY) Pluristem (PSTI) LEXICON (LXRX) Regeneron (REGN) Anacor (ANAC) Human Longevity (HLI) Sarepta (SRPT) Amgen (AMGN) Agenus (AGEN Editas (EDIT) Alder Biopharmaceuticals (ALDR) PTC Therapeutics (PTCT) OncoCyte (OCX) Gilead (GILD) VANDA (VNDA) Revlimid (lenolidamide) Inovio (INO) Biogen Idec (BIIB) Seattle Genetics (SGEN) NEKTAR (NKTR)) Abbott Laboratories (ABT) Sanofi (SNY) Adaptimmune (ADAP) GlaxoSmithKline (GSK) NOVOCURE (NVCR) Xoma (XOMA) AstraZeneca (AZN) Agenus (AGEN) Trastuzumab-DM1 JOUNCE THERAPEUTICS (JNCE) Zerenex ADVENTRIX (ANX) Benlysta (belimumab) ABBVIE (ABBV) Genentech SERES THERAPEUTICS (MCRB) Dendreon (DNDN) Alnylam (ALNY) Theravance Bio Pharma (TBPH) Ariad (ARIA) AGOS (ARGS) Cytokinetics (CYTK) KERYX (KERX) Sequenom (SQNM) Sanofi (SNA) TOKAI (TKAOI) CRISPR Therapeutics (CRSP) Merck (MRK) Rapamune Micromet (MITI) ACADIA (ACAD) Multiple Myeloma Auspex (ASPX) Velcade (bortezomib) Advaxis (ADXS) JUNO (JUNO) REGULUS (RGLS)